Graph-based machine learning is promising for DDI prioritization and hypothesis generation but remains insufficient for independent clinical decision-making, and future studies should use standardized benchmarks, leakage-aware validation, calibrated uncertainty, reproducible pipelines, validated explanations, and external or prospective evaluation.
Md. Tuhin Reza, Md. Abdul Kader, Wissem Inoubli et al.· Pharmaceuticals· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.